The Mega Online Bookstore
Welcome Guest | Login | Home | Contact Us | Live Chat

The Indian Pharmaceutical Industry Since Independence 1st Edition

The Indian Pharmaceutical Industry Since Independence 1st Edition,8174740066,9788174740069


Usually Ships in 4 Days.

Ships From New York

Free Shipping within U.S.A

International Shipping?

Check Delivery Estimate and Shipping Cost for your country

Book Information

Publisher:ICRA Limited
Published In:2001
Binding Type:Paperback
Weight:1.74 lbs
Pages:pp. xix + 244, Illus., Tables, Glossary, References

The Title "The Indian Pharmaceutical Industry Since Independence 1st Edition" is written by Vandana Gangwar. This book was published in the year 2001. The ISBN number 8174740066|9788174740069 is assigned to the Paperback version of this title. The book displayed here is a 1st Edition edition. This book has total of pp. xix + 244 (Pages). The publisher of this title is ICRA Limited. We have about 10 other great books from this publisher. The Indian Pharmaceutical Industry Since Independence 1st Edition is currently Available with us.

Related Books

Medicinal Plants of India Reprint,8123902778,9788123902777

Medicinal Plants of India ...

Rasheeduz Zafar

Our Price: $ 9.30

Herbal Drugs Industry A Practical Approach to Industrial Pharmacognosy 3rd Reprint,8190018116,9788190018111
85 %

Herbal Drugs Industry A P ...


List Price: $ 200.00

Our Price: $ 30.66

The Indian Tea Industry,8174740058,9788174740052

The Indian Tea Industry

U. Sailesh, Vin ...

Our Price: $ 94.22

Medicinal and Pharmaceutical Chemistry 2nd Edition,8185731004,9788185731001
84 %

Medicinal and Pharmaceuti ...

Harkishan Singh ...

List Price: $ 100.00

Our Price: $ 15.99

Indian Plants and Drugs With Their Medical Properties and Uses 3rd Indian Print,8187067071,9788187067078

Indian Plants and Drugs W ...

K.M. Nadkarni

Our Price: $ 21.50

The Indian Cement Industry 1st Edition

The Indian Cement Industr ...

Rajeev Thakur, ...

Our Price: $ 130.99

About the Book

This report has two sections. In the first section, we have analysed the major factors that govern the Dynamics of the Pharmaceutical Industry in India. The analysis bases itself on industry-level data and the annual reports of 31 companies for the last five years. Of these 31 companies, 18 are Indian with the rest 13 being subsidiaries of multinational corporations. The 31 companies mentioned accounted for over 68% of the industry revenue in India during FY98. The second section of the report is a corporate digest with abstracts on 31 prominent Pharmaceutical Companies in India.

The focus of the scrutiny in the first section is about the dynamics of the Pharmaceutical Industry and the factors that determine its operations and profitability. Chapter 1. Introduces the industry, giving it a historical perspective, and presents the status of the healthcare infrastructure in the country. Chapter 2. Discusses the importance of Research and Development in the Pharmaceutical Industry. The focus here is on the areas of research, cost of research and recent trends in research. Chapter 3. Looks at the role of regulation, covering issues related to patents, the Drug Price Control Order (DPCO), and quality. Chapter 4. Sketches the global pharmaceutical scenario, covering issues relating to size, growth, therapeutic segments and market. Chapter 5. Focuses on the market structure for the Indian Pharmaceutical Industry. The issues discussed here include market size, growth, structure, price behaviour and global trade. Chapter 6. Discusses the therapeutic segments in the Indian market in greater detail. in Chapter 7. We have looked at the Economics of the pharmaceutical Business in India. The issues covered include capital structure, operating cost and its components, besides the returns generated by the industry. This chapter also looks at the financial performance of the 31 pharmaceutical companies in our sample and their relative positions. Finally, Chapter 8. Presents our conclusions, with a discussion on the key success factors for the industry, the emerging trends in the global and domestic markets, and the outlook for Indian companies.

The second section of the report, that is the corporate digest, presents two-page abstracts on 31 prominent companies in the Indian Pharmaceutical Industry. The format for the abstracts is the same for all companies. The first page presents the key financial indicators and the basic information about the company. The second page presents analytical briefs on the operations, financials, plans and prospects of the company. The abstracts are based on the company's published accounts for the past several years, which have analysed in considerable detail.


1. Introduction
2. Role of research and development
3. Regulation
4. Global scenario
5. Indian market structure
6. Therapeutic segments
7. Economics
8. Conclusion
9. Annexures

1. Ambalal Sarabhai Enterprises Limited
2. Aurobindo Pharma Limited
3. Burroughs welcome (India) Limited
4. Cheminor Drugs Limited
5. Cipla Limited
6. Core Healthcare Limited
7. Dr. Reddy's Laboratories Limited
8. E Merck (India) Limited
9. German Remedies Limited
10. Glaxo India Limited
11. Hoechst Marion Roussel Limited
12. Infar (India) Limited
13. Ipca Laboratories Limited
14. Knoll Pharmaceuticals Limited
15. Lupin Chemicals Limited
16. Lupin Laboratories Limited
17. Lyka Labs Limited
18. Morepen Laboratories Limited
19. Nicholas Piramal India Limited
20. Novartis India Limited
21. Orchid Chemicals & Pharmaceuticals Limited
22. Parke-Davis (India) Limited
23. Pfizer Limited
24. Ranbaxy Laboratories Limited
25. Rhone Poulenc (India) Limited
26. RPG lifesciences/searle (India) Limited
27. Smithkline Beecham Pharmaceuticals Limited
28. Sun Pharmaceutical Industries Limited
29. Torrent Pharmaceuticals Limited
30. Wockhardt Limited
31. Wyeth Lederle Limited